come back to us when they miss an end point in Phase 2... very easy to do.. statistically a miracle to make it through 3 phases, without having to go back and repeat something, or revise an endpoint, or select the wrong patients, or safety or efficacy issues. 17 patients ahahah you have NOTHING YET.
Stem cells ramping up.., page-57
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.175(13.0%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $18.69M | 12.89M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2778 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 23853 | 13 |
View Market Depth
| Last trade - 13.56pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |